Z217-0850 Screening compound: 2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d][1,3]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one

Z217-0850 Screening compound: 2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d][1,3]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one
Z217-0850 Screening compound: 2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d][1,3]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound Z217-0850
2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d][1,3]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Z217-0850

Molecular Formula

C24H27N7OS (C24 H27 N7 OS)

Compound Name

2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d][1,3]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one

IUPAC name

2-{methyl[3-methyl-1-(4-methylphenyl)-1H-pyrazolo[34-d][13]thiazol-5-yl]amino}-1-[4-(pyridin-2-yl)piperazin-1-yl]ethan-1-one

SMILES

Cc(c1c2nc(N(C)CC(N(CC3)CCN3c3ncccc3)=O)s1)nn2-c1ccc(C)cc1

InChI

InChI=1S/C24H27N7OS/c1-17-7-9-19(10-8-17)31-23-22(18(2)27-31)33-24(26-23)28(3)16-21(32)30-14-12-29(13-15-30)20-6-4-5-11-25-20/h4-11H,12-16H2,1-3H3

InChI Key

FWZAIIXANQRFFA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27634627

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.841

Distribution Coefficient, logD

3.832

Water Solubility, LogSw

-3.82

Polar Surface Area

55.958

Acid Dissociation Constant (pKa)

17.18

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.33

Z217-0850 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with Z217-0850 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Z217-0850?
Check Price and Availability of Z217-0850, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Z217-0850 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Z217-0850
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Z217-0850
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Z217-0850 available by request